Kaitlin Dyer

Kaitlin Dyer is a born-Appalachian, raised-Midwestern, transplanted-Californian queer poet. She’s the author of Alter Lives of Alter Egos (Dancing Girl Press, 2015) and her poetry has appeared in journals such as Witness, Crab Orchard Review, and PANK, among others. Forthcoming work is expected from Appalachian Review and Cimarron Review. Follow her at kaitlindyer.com.

Kay Abesamis

Board Member

Kay Abesamis is a seasoned pharmaceutical commercial leader with deep experience in both science and business. Kay has led global teams to successfully launch new cancer treatments, including the prostate cancer drug Talzenna®, and has helped shape strategies for other major therapies in blood disorders, biosimilars, and immunology. Known for a collaborative and diplomatic leadership style, Kay thrives in complex, fast-changing environments and builds strong partnerships across cultures and disciplines.

With a background in molecular biology and an MBA in marketing and finance, Kay brings a unique blend of scientific insight and commercial acumen. Kay has worked internationally – from the U.S. to Europe and Asia – and has contributed to projects ranging from contraceptive innovation to biotech licensing. Whether guiding product launches, evaluating new drug candidates, or managing alliances, Kay consistently drives impact through thoughtful strategy and clear execution.

Tagged:

Khaliah Johnson

Khaliah Johnson received her medical degree at Stanford University in Palo Alto, CA in 2007. She then went on to train in General Pediatrics at the Johns Hopkins Hospital in Baltimore, MD. Her desire to serve children and families facing complex, life-threatening illness led her to pursue fellowship training in Pediatric Palliative Care at the Children’s Hospital of Philadelphia.